Skip to main content
Screener/Healthcare/Biotechnology

ZVRA — Zevra Therapeutics, Inc.

NASDAQ
$11.40-0.18 (-1.55%)
Small CapUnder $20HealthcareFastest Growing
$7.51
$15.04
$11.36
$11.58
EPS (TTM)$2.15
P/E Ratio5.42
Dividend Yield—
Market Cap$686.3M
Volume56K
Prev Close$11.58
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$36.2M$37.9M$0.6094.8%104.6%
Q4 '25$34.1M$12.2M$0.2095.5%35.6%
Q3 '25$26.1M-$544K$-0.0194.0%-2.1%
Q2 '25$25.9M$74.7M$1.3652.2%288.7%
Q1 '25$20.4M-$3.1M$-0.0693.4%-15.2%
Q4 '24$12.0M-$35.7M$-0.6788.7%-296.8%
Q3 '24$3.7M-$33.2M$-0.6937.7%-899.2%
Q2 '24$4.4M-$19.9M$-0.4819.7%-447.9%
Get Your Daily Market Recap